Ostrom QT, Cioffi G, Waite K et al (2021) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018. Neurooncology 23:iii1–iii105. https://doi.org/10.1093/neuonc/noab200
Garcia C, Slone S, Dolecek T et al (2019) Primary brain and Central Nervous System Tumor Treatment and Survival in the United States, 2004–2014 (S30.004). https://doi.org/10.1212/wnl.92.15_supplement.s30.004. Neurology 92:
Maggio I, Franceschi E, Tosoni A et al (2021) Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncol 10. https://doi.org/10.2217/cns-2021-0003
Chen L, Li D, Lu Y et al (2019) Preoperative embolization Versus Direct surgery of meningiomas: a Meta-analysis. World Neurosurg 128:62–68. https://doi.org/10.1016/j.wneu.2019.02.223
Aizer AA, Bi WL, Kandola MS et al (2015) Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer 121:4376–4381. https://doi.org/10.1002/cncr.29639
Moreau JT, Hankinson TC, Baillet S, Dudley RWR (2020) Individual-patient prediction of meningioma malignancy and survival using the Surveillance, Epidemiology, and end results database. https://doi.org/10.1038/s41746-020-0219-5. npj Digital Medicine 3:
Seifman MA, Lewis PM, Rosenfeld JV, Hwang PYK (2011) Postoperative intracranial haemorrhage: a review. Neurosurg Rev 34:393–407. https://doi.org/10.1007/s10143-010-0304-3
Cohen JA, Alan N, Seicean A, Weil RJ (2017) Risk associated with perioperative red blood cell transfusion in cranial surgery. Neurosurg Rev 40:633–642. https://doi.org/10.1007/s10143-017-0819-y
Rajagopalan V, Chouhan RS, Pandia MP et al (2019) Effect of intraoperative blood loss on Perioperative complications and neurological outcome in adult patients undergoing elective brain tumor surgery. J Neurosciences Rural Pract 10:631–640. https://doi.org/10.1055/s-0039-3399487
Hooda B, Chouhan RS, Rath GP et al (2017) Effect of tranexamic acid on intraoperative blood loss and transfusion requirements in patients undergoing excision of intracranial meningioma. J Clin Neurosci 41:132–138. https://doi.org/10.1016/j.jocn.2017.02.053
Article CAS PubMed Google Scholar
Prudovsky I, Kacer D, Zucco VV et al (2022) Tranexamic acid: beyond antifibrinolysis. Transfusion 62. https://doi.org/10.1111/trf.16976
(2019) Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet 394:1713–1723. https://doi.org/10.1016/s0140-6736(19)32233-0
Liu Z-G, Yang F, Zhu Y-H et al (2022) Is Tranexamic Acid Beneficial in Open spine surgery? And its effects Vary by Dosage, Age, sites, and locations: a Meta-analysis of Randomized controlled trials. World Neurosurg 166:141–152. https://doi.org/10.1016/j.wneu.2022.07.044
Baehr A (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomized, placebo-controlled, phase 3 superiority trial. J Emerg Med 55:298. https://doi.org/10.1016/j.jemermed.2018.06.025
Germans M, Dronkers W, Baharoglu M et al (2022) Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Brain Spine 2:101195. https://doi.org/10.1016/j.bas.2022.101195
Alabdulkarim A, Al Qurashi AA, Odeh NB et al (2023) Effect of Tranexamic Acid on the reduction of blood loss in craniosynostosis surgery: a systematic review and Meta-analysis. Plast Reconstr Surg - Global Open 11:e5021. https://doi.org/10.1097/gox.0000000000005021
Ravi GK, Panda N, Ahluwalia J et al (2021) Effect of tranexamic acid on blood loss, coagulation profile, and quality of surgical field in intracranial meningioma resection: a prospective randomized, double-blind, placebo-controlled study. Surg Neurol Int 12:272. https://doi.org/10.25259/sni_296_2021
Article PubMed PubMed Central Google Scholar
Rebai L, Mahfoudhi N, Fitouhi N et al (2021) Intraoperative tranexamic acid use in patients undergoing excision of intracranial meningioma: Randomized, placebo-controlled trial. Surg Neurol Int 12:289. https://doi.org/10.25259/sni_177_2021
Article PubMed PubMed Central Google Scholar
Clynch AL, Gillespie CS, Richardson GE et al (2023) Tranexamic acid use in meningioma surgery – A systematic review and meta-analysis. J Clin Neurosci 110:53–60. https://doi.org/10.1016/j.jocn.2023.01.012
Article CAS PubMed Google Scholar
Wijaya JH, July J, Quintero-Consuegra M, Chadid DP (2023) A systematic review and meta-analysis of the effects of tranexamic acid in surgical procedure for intracranial meningioma. J Neurooncol 161:383–393. https://doi.org/10.1007/s11060-023-04237-2
Article CAS PubMed Google Scholar
Adnan Khalid U, Nazir N, Raza et al (2023) A comparison of the Use of Tranexamic Acid versus Placebo in patients undergoing excision of Intracranial Meningioma. Pakistan J Neurol Surg 26:654–666. https://doi.org/10.36552/pjns.v26i4.822
Li S, Liu M, Yang J et al (2024) Intravenous tranexamic acid for intracerebral meningioma resections: a randomized, parallel-group, non-inferiority trial. J Clin Anesth 92:111285. https://doi.org/10.1016/j.jclinane.2023.111285
Article CAS PubMed Google Scholar
Li T, Higgins JP, Deeks JJ (2019) Collecting data. Cochrane Handb Syst Reviews Interventions 109–141. https://doi.org/10.1002/9781119536604.ch5
Page MJ, McKenzie J, Bossuyt P et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Center for Open Science
Higgins JPT, Altman DG, Gotzsche PC et al (2011) The Cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343:d5928–d5928. https://doi.org/10.1136/bmj.d5928
Article PubMed PubMed Central Google Scholar
Sutanto S, Yulianti Bisri D, Bisri T (2019) Pengaruh Asam Traneksamat Intravena terhadap Jumlah Perdarahan Intraoperatif Dan Kebutuhan Transfusi Pada Operasi Meningioma. Jurnal Neuroanestesi Indonesia 8:8–16. https://doi.org/10.24244/jni.vol8i1.200
Goodnough LT, Shander A (2012) Patient blood management. Surv Anesthesiology 56:278–279. https://doi.org/10.1097/01.sa.0000422039.22134.87
Furtmüller R, Schlag MG, Berger M et al (2002) Tranexamic acid, a widely used Antifibrinolytic Agent, causes convulsions by a γ-Aminobutyric AcidA receptor antagonistic effect. J Pharmacol Exp Ther 301:168–173. https://doi.org/10.1124/jpet.301.1.168
Lecker I, Wang D-S, Romaschin AD et al (2012) Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 122:4654–4666. https://doi.org/10.1172/jci63375
Article CAS PubMed PubMed Central Google Scholar
Stone TJ, Rowell R, Jayasekera BAP et al (2018) Review: molecular characteristics of long-term epilepsy‐associated tumours (LEATs) and mechanisms for tumour‐related epilepsy (TRE). Neuropathol Appl Neurobiol 44:56–69. https://doi.org/10.1111/nan.12459
Article CAS PubMed Google Scholar
Adhikari S, Walker BC, Mittal S (2021) Pathogenesis and Management of Brain Tumor-Related Epilepsy. In: Gliomas. Exon Publications. 199–210
Myers SP, Kutcher ME, Rosengart MR et al (2019) Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism. J Trauma Acute Care Surg 86:20–27. https://doi.org/10.1097/ta.0000000000002061
Article CAS PubMed Google Scholar
Taeuber I, Weibel S, Herrmann E et al (2021) Association of Intravenous Tranexamic Acid with thromboembolic events and mortality. JAMA Surg 156:e210884. https://doi.org/10.1001/jamasurg.2021.0884
留言 (0)